This article compares Constellation Energy (CEG) and Duke Energy (DUK), two major U.S. electricity producers, to determine which offers a more compelling investment opportunity. Driven by increasing demand from AI data centers, manufacturing reshoring, and electric vehicles, both companies are well-positioned to benefit from the clean energy transition. The analysis concludes that Duke Energy is the better pick due to its stronger earnings estimates, better dividend yield, extensive capital investment plans, cheaper valuation, and higher share price return.

Freedom Broker has initiated coverage of EQT Corp. with a buy rating and a price target of $79.00, suggesting a 50% upside from its current trading price of $52.55. The firm highlighted EQT's strong position to benefit from improving U.S. natural gas market fundamentals, attributing this to its scale, high-quality asset base, and disciplined operating model. Recent positive developments include strong Q1 2026 financial results, an upgraded outlook from Moody's Ratings due to significant debt reduction, and strategic real estate acquisitions.

Gartner has released its annual report identifying the top eight supply chain technology trends for 2026, focusing on advancements in AI, robotics, and automation. These technologies are categorized into themes of autonomy and agency, specialization and intelligence, and trust and governance, all aimed at creating more connected, intelligent, and adaptive supply chains. The report emphasizes that these trends are catalysts for transformation, urging organizations to strategically evaluate and integrate them for resilience and competitive advantage.

This article provides financial data on Jacobs Solutions Inc. (MUN:Z0Y), specifically focusing on its enterprise value to forward revenue. It highlights the company's listing on the Munich Stock Exchange and offers an overview of its financials within the technology services sector. The content appears to be a stub or a data point from a larger financial platform like TradingView.

JPMorgan Chase & Co. has increased its price target for Walt Disney (NYSE:DIS) stock to $140 from $139, maintaining an "overweight" rating and suggesting a 44.8% upside. This positive outlook aligns with broader Wall Street sentiment, which generally holds a "Moderate Buy" consensus for Disney with an average analyst target of $133.60. Despite a recent 2.0% dip in shares to $96.68, the company recently surpassed quarterly EPS and revenue estimates, though its stock remains below its 52-week high.

RTX subsidiary Raytheon is constructing a large space telescope for the Lazuli Space Observatory, a mission supported by Schmidt Sciences. This telescope will study planets, distant galaxies, and astronomical phenomena, demonstrating Raytheon's expanding capabilities in high-end scientific systems. The project emphasizes advanced technological features such as an unobstructed aperture and an off-axis design, though its near-term financial impact on RTX is not expected to be significant.

Dream America Marketing Services, Ltda. has acquired Sadot Latam LLC from Sadot Group Inc. for $1,000, as per a share purchase agreement on June 26, 2026. The acquisition also includes a profit-sharing arrangement where Dream America will pay 27.5% of cash generated from certain receivables held by SDOT Latam and SDOT LLC. The payment will be made via wire transfer.

The quantum computing industry faces "bubble" concerns as stock valuations for companies like D-Wave (QBTS) and Rigetti (RGTI) have surged, outpacing current revenues and profitability. While IonQ (IONQ) shows stronger growth and commercial traction, the entire sector struggles with negative operating margins, high R&D spending, and reliance on external funding. The presence of tech giants like Intel (INTC) and IBM (IBM) in the quantum space also poses a significant external threat to smaller, pure-play quantum companies.

Oracle recently reported strong cloud performance with 93% infrastructure revenue growth and a $638 billion contracted backlog, yet its stock is down 23.33% YTD due to significant AI infrastructure capital expenditures. Despite investor nervousness from negative free cash flow and increased liabilities, analysts see substantial upside, with some models suggesting Oracle could reach $400 per share by 2030, potentially pushing its market cap past $1 trillion. This relies on the company successfully scaling its OCI revenue to $144 billion and increasing AI infrastructure gross margins, but execution risk on its $55 billion annual CapEx commitment remains a challenge.

Beeline Medicines has raised an additional $126.3 million in its Series A extension, bringing its total funding to $426.3 million. This significant investment will be used to advance the company's portfolio of Bristol Myers Squibb-licensed drugs for immune conditions, including afimetoran for systemic lupus erythematosus, which is currently in mid-stage testing. Investors, including Bain Capital and Bristol Myers, are showing strong conviction ahead of a data readout for afimetoran, highlighting a strategy of funding biotechs built around advanced experimental drugs.